A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use of CUSA-081 for Dysfunctional Central Venous Access Devices (CVADs)

Administered By

Awarded By

Contributors

Start/End

  • March 27, 2020 - March 31, 2023